V S S Abhinav Ayyadevara

5PUBLICATIONS
37CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 10, 2026
Interferon beta drives therapy resistance in a patient-derived model of high-grade serous ovarian cancer.

|Mar 28, 2025
DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition.

V S S Abhinav Ayyadevara, Gerald Wertheim, Shikha Gaur

|Dec 08, 2023
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress.

Marissa L Calbert, Gurushankar Chandramouly, Clare M Adams

|Jan 22, 2021
Calcium signaling on Jurkat T cells induced by microbeads coated with novel peptide ligands specific to human CD3ε.

Armin Ahmadi, V S S Abhinav Ayyadevara, Jerome Baudry

Pageof 1

Frequent Collaborators

3 joint publications

Christian Hurtz

2 joint publications

Srividya Swaminathan

2 joint publications

Wayne E Childers

2 joint publications

Monika Toma